Bill106th CongressFiled Apr 13, 2000Health
H.Res. 477
Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Apr 13, 2000)
Expresses the sense of the House of Representatives that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.
What just happenedApr 24, 2000
Referred to the Subcommittee on Health and Environment.
Who’s behind it
Rep. Baldacci, John Elias [D-ME-2](D-ME)Sponsor
1committees4actions9subjects
- Introduced in HouseApr 13, 2000
- Apr 24, 2000CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Apr 13, 2000IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - Apr 13, 2000IntroReferralIntro-H
Introduced in House
- Apr 13, 2000IntroReferral1000
Introduced in House